Sitemap

  • Slideshow
  • Drug Registration Guidance Document
  • Healthcare Professional
  • Directives
  • Directives - Plasma Products Lot Release (2)
  • Directive - Prescriptions
  • Directives Biologics
  • Directives NCE
  • Directives Traditional
  • Directives Health General
  • Directives Non Prescription
  • Directives Veterinary
  • Directives Combo Products
  • Directives - Bioequivalence(BE)
  • Directives - Cosmetic
  • Directives - Clinical Trial
  • Directives - Pharmacovigilance
  • Directives - GMP
  • Directives - Laboratory & Quality Control
  • Directives - Active Pharmaceutical Ingredient (API)
  • Directives - Vaccine Lot Release
  • Directives - Plasma Products Lot Release
  • Directives - Licensing
  • Directives - FEO
  • Training and Seminars
  • FAQ
  • FAQ Quest3+
  • FAQ API
  • FAQ Generic
  • FAQ Biologics
  • FAQ NCE
  • FAQ Traditional
  • FAQ Health General
  • FAQ Combo Products
  • FAQ Bioequivalence(BE)
  • FAQ Cosmetic
  • FAQ Clinical Trial
  • FAQ Pharmacovigilance
  • FAQ GMP
  • FAQ Laboratory & Quality Control
  • QUEST
  • Circulars
  • Circulars Inspection (2)
  • Circular - Prescription
  • Circulars Biologics
  • Circulars NCE
  • Circulars Traditional
  • Circulars Health Supplements
  • Circulars - Non Prescription
  • Circulars - Veterinary
  • Circulars - Combo Products
  • Circulars - Cosmetics
  • Circulars - Clinical Trial
  • Circulars - Bioequivalence (BE)
  • Circulars - Active Pharmaceutical Ingredient (API)
  • Circulars - Pharmacovigilance
  • Circulars Plasma Products Lot Release
  • Circulars Vaccine Lot Release
  • Circulars Laboratory & Quality Control
  • Circulars GMP
  • Circulars - General
  • Announcement 2013
  • Announcement 2014
  • Announcement 2012
  • Announcement 2010
  • Announcement 2011
  • Announcement 2015
  • Sebut Harga 2016
  • Announcement 2017
  • QUEST3+
  • Publications
  • MADRAC Bulletin
  • REAKSI Drug Safety News
  • Berita Ubat-ubatan
  • NPRA Publications
  • DCA Annoucement
  • Announcement Main
  • Announcement - Laboratory & Quality Control (2)
  • Announcement QUEST
  • Announcement 2016
  • QUEST3+ Announcement 2016
  • Announcement - Generic
  • Announcement - Biologics
  • Announcement - NCE
  • Announcement - Traditional
  • Announcement - Health Supplements
  • Announcement - Veterinary
  • Announcement - Combo Products
  • Announcement - Bioequivalence(BE)
  • Announcement - Cosmetic
  • Announcement - Clinical Trial
  • Announcement - Pharmacovigilance
  • Announcement - GMP
  • Announcement - Laboratory & Quality Control
  • Announcement - General
  • Announcement 2017 (2)
  • Announcement 2018 (2)
  • Safety Alerts Main bm
  • Safety Alert 2014
  • Safety Alert 2015
  • Safety Alert 2016
  • Safety Alert 2017
  • Safety Alert 2018
  • Announcement QUEST
  • Industries
  • Laboratory & Quality Control
  • Bioequivalence
  • Prescription
  • Regulation Basic
  • Directive - General
  • Traditional
  • Traditional - Guideline
  • Guidelines Central
  • Guidelines - General
  • Guidelines - Prescriptions
  • Guidelines - Biologics
  • Guidelines - NCE
  • Guidelines - Traditional
  • Guidelines - Health General
  • Guidelines - Non Prescription
  • Guidelines - Veterinary
  • Guidelines - Combo Products
  • Guidelines - Cosmetic
  • Guidelines - Clinical Trial
  • Guidelines - Pharmacovigilance
  • Guidelines - GMP
  • Guidelines - Laboratory & Quality Control
  • Guidelines - Active Pharmaceutical Ingredient (API)
  • Guidelines - Vaccine Lot Release
  • Guidelines - Plasma Products Lot Release
  • Guidelines - Licensing
  • Guidelines - FEO
  • Guidelines - Others
  • Guidelines - Good Laboratory Practice
  • Application Form
  • Application Form - Prescriptions
  • Application Form - Biologics
  • Application Form - NCE
  • Application Form - Traditional
  • Application Form - Health Supplement
  • Application Form - Non Prescription
  • Application Form - Veterinary
  • Application Form - Combo Products
  • Application Form - Bioequivalence(BE)
  • Application Form - Cosmetic
  • Application Form - Clinical Trial
  • Application Form - Pharmacovigilance
  • Application Form - Laboratory & Quality Control
  • Application Form - Active Pharmaceutical Ingredient (API)
  • Application Form - Vaccine Lot Release
  • Application Form - Plasma Products Lot Release
  • Application Form - Licensing
  • Application Form - FEO
  • Submission Generic
  • Product Validation Generic
  • Section A Generic
  • none
  • test
  • Press Release
  • Press Release 2018
  • Press Release 2017
  • Press Release 2016
  • Press Release 2015
  • Press Release 2014
  • Press Release 2013
  • Press Release 2012
  • Press Release 2011
  • Press Release 2010
  • Press Release 2009
  • Press Release 2008
  • Press Release 2007
  • Press Release 2006
  • Press Release 2016

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Newsletter Subsription

Site Last Modified

  • Last Modified: Selasa 16 Julai 2019, 11:12:19.
© Copyright 2019 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Menu Utama

Choose Your Language